Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

126
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
126

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A standardized Ferula supplement (Menotrack) to prevent symptoms in post-menopause: a 3-month supplement registry.

Panminerva medica·2026
Same author

The Role of Worry and Emotional Intelligence in Depression in a Non-Clinical and Subclinical Sample.

European journal of investigation in health, psychology and education·2026
Same author

Examining the Mediation Role of Emotion Regulation and Hope in the Impact of COVID-19 on Psychological Well-Being and Mental Health.

International journal of psychology : Journal international de psychologie·2026
Same author

Sarcopenia: effects of Robuvit® supplementation on loss of muscular mass and strength.

Minerva medica·2026
Same author

Unveiling the Dark: Exploring the Nomological Consistency of the Short Dark Triad and Dirty Dozen Scales.

Europe's journal of psychology·2026
Same author

Improvement in venous ulcer closure and healing with Centellicum®.

Minerva surgery·2025

相关实验视频

Updated: Jul 4, 2025

A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats
10:15

A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats

Published on: November 6, 2019

8.3K

皮cnogenol®改善了中风后患者的认知功能:一个为期6个月的研究

Gianni Belcaro1, Mark Dugall2, Morio Hosoi2

  • 1IRVINE3 Labs, Chieti-Pescara University, Chieti, Italy - cardres@abol.it.

Journal of neurosurgical sciences
|February 1, 2024
PubMed
概括

在中风后的患者中补充Pycnogenol®可以改善认知功能 (COFU) 和恢复. 这项试点研究发现,这种补充剂是安全有效的,有可能减少大脑胀和小事故.

更多相关视频

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:54

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

253
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.0K

相关实验视频

Last Updated: Jul 4, 2025

A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats
10:15

A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats

Published on: November 6, 2019

8.3K
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:54

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

253
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.0K

科学领域:

  • 神经学 神经学
  • 药理学 药理学是指药理学的学科.
  • 老年学是指老年学的学科.

背景情况:

  • 脑卒中后的认知障碍是一个重大挑战.
  • 早期干预可以改善患者的治疗结果.
  • 皮克诺日 (Pycnogenol®) 是一种具有抗氧化特性的植物提取物.

研究的目的:

  • 评估Pycnogenol®补充剂对中风后患者认知功能的影响.
  • 评估Pycnogenol®在这个人群中的安全性和耐受性.
  • 探索潜在的机制,如减少大脑和自由基.

主要方法:

  • 一项为期6个月的试点研究,涉及38名中风后患者.
  • 患者每天接受标准管理 (SM) 或SM加150毫克Pycnogenol®.
  • 评估了认知功能 (COFU),小事故,精神病发作和血自由基.

主要成果:

  • 与对照组相比,pycnogenol®补充剂显著改善了COFU的主要参数 (P<0.05).
  • 补充剂的患者经历的迷你事故,精神病发作和痛苦较少.
  • 在Pycnogenol®组中观察到血自由基的减少和更好的整体恢复.

结论:

  • 补充Pycnogenol®似乎可以增强中风后患者的恢复和认知功能正常化.
  • 它是一种安全和可管理的辅助疗法,可以减少局部脑.
  • 需要对更大的队列和更长的随访进行进一步的研究来证实这些发现.